Dexamethason Krka

Medicinal product

(Invented) name

Dexamethason Krka

Active substance (s)

Deksametazono natrio fosfatas

Strength

4 mg/ml

Pharmaceutical form

injekcinis ar infuzinis tirpalas

Route (s) of administration

leisti į veną, leisti į raumenis, leisti į sąnarį

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

H02AB02, Dexamethasone

Marketing authorisation holder

KRKA, d.d., Novo mesto, Slovėnija

Date of authorisation

1994-06-22

Date of renewal

2010-11-10

Documents

2220 Pakuotės lapelis 2023 05 26.docx

2220 Dexamethason Krka inj_inf RPP 2023 05 26.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10a

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Ampulėje (1 ml) yra	1 ml
Deksametazono natrio fosfatas	4 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
5220	577	1000577	ampulė	1 ml N25		Receptinis	LT/1/94/2220/002	Tiekiama	-	-	No	-	-	Download
111040	97151	1097151	ampulė	1 ml N10		Receptinis	LT/1/94/2220/016	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2010-11-10	Perregistruotas
1994-06-22	Registruotas